| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |